This week, Thermo Fisher Scientific Inc., the world leader in serving science, announced it has completed the acquisition of Prionics AG, a privately held animal health diagnostics company.

Founded in 1997, Prionics is headquartered in Zurich, Switzerland, and has a major production facility in Lelystad, the Netherlands. Prionics’ product line of more than 50 diagnostic test kits, accessories and biochemicals expands the portfolio of animal health testing products under the Life Technologies brand.

“Prionics adds a unique blend of expertise and diagnostic solutions to new and existing customers,” said Kirk Adams, Ph.D., global animal health leader in a news release. “Improved accessibility to animal testing benefits both veterinarians and livestock producers.”

“Combining Prionics under the Life Technologies’ brand is certainly a win-win, since the products and capabilities are highly complementary,” said Dr. Markus Moser, CEO of Prionics. “We believe this will have a strong and worldwide impact on the animal health industry.”

Prionics brings a state-of-the-art infrastructure along with a certified tuberculin manufacturing facility, plus additional enzyme-linked immunosorbent assays (ELISA) under the Life Technologies brand

Source: Thermo Fisher Scientific